BGNE - BeiGene Ltd - ADR
IEX Last Trade
191.6
-6.900 -3.601%
Share volume: 293,387
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$198.50
-6.90
-3.48%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-02-27 | 2023-05-04 | 2023-08-02 | 2023-11-09 | 2024-02-26 | 2024-05-08 | |
| Total revenue | 341.572 M | 387.628 M | 380.095 M | 447.801 M | 595.261 M | 781.308 M | 634.409 M | 751.652 M | |
| Cost of revenue | 71.173 M | 76.543 M | 73.522 M | 81.789 M | 95.990 M | 96.309 M | 105.832 M | 124.935 M | |
| Gross profit | 270.399 M | 311.085 M | 306.573 M | 366.012 M | 499.271 M | 684.999 M | 528.577 M | 626.717 M | |
| 15.05% | -1.45% | 19.39% | 36.41% | 37.20% | -22.84% | 18.57% | |||
| Operating expenses | 709.610 M | 749.255 M | 775.007 M | 737.083 M | 817.798 M | 817.680 M | 910.534 M | 888.065 M | |
| Selling general and admin | 331.403 M | 322.892 M | 328.984 M | 328.499 M | 395.034 M | 364.421 M | 416.547 M | 427.427 M | |
| Research and development | 378.207 M | 426.363 M | 446.023 M | 408.584 M | 422.764 M | 453.259 M | 493.987 M | 460.638 M | |
| Total expenses | 780.971 M | 825.985 M | 848.717 M | 819.059 M | 913.976 M | 915.276 M | 1.018 B | 1.013 B | |
| 5.76% | 2.75% | -3.49% | 11.59% | 0.14% | 11.25% | -0.51% | |||
| Operating income | -439.399 M | -438.357 M | -468.622 M | -371.258 M | -318.715 M | -133.968 M | -383.795 M | -261.348 M | |
| Ebit | -439.399 M | -438.357 M | -468.622 M | -371.258 M | -318.715 M | -133.968 M | -383.795 M | -261.348 M | |
| Pretax income | -557.585 M | -551.238 M | -430.965 M | -336.939 M | -367.463 M | 229.338 M | -350.772 M | -243.426 M | |
| -1.14% | -21.82% | -21.82% | 9.06% | -162.41% | -252.95% | -30.60% | |||
| Income tax | 13.864 M | 6.318 M | 9.571 M | 11.492 M | 13.674 M | 13.925 M | 16.781 M | 7.724 M | |
| Net income basic | -571.449 M | -557.556 M | -440.536 M | -348.431 M | -381.137 M | 215.413 M | -367.553 M | -251.150 M | |
| 2.43% | 20.99% | 20.91% | -9.39% | 156.52% | -270.63% | 31.67% | |||
| Net income | -571.449 M | -557.556 M | -440.536 M | -348.431 M | -381.137 M | 215.413 M | -367.553 M | -251.150 M | |
| 2.43% | 20.99% | 20.91% | -9.39% | 156.52% | -270.63% | 31.67% |